access intranet after hours circle-arrow apply blog caret circle arrow close closer look community outreach community outreach contact contact us down arrow facebook lock solid find a provider find a clinical trial find a provider find a researcher find faculty find-a-service how to apply join leadership left arrow locations logo make a gift map location maximize minimize my chart my chart notification hp notification lp next chevron right nxt prev pay your bill play previous quality and safety refer a patient request a speaker request appointment request an appointment residents corner rss search search jobs Asset 65 submit a story idea symptom checker Arrow Circle Up twitter youtube Dino Logo External Link University Logo Color University Logo Solid Health Logo Solid Arrow Right Circle Book Calendar Date Calendar Search Date Diploma Certificate Dollar Circle Donate Envelope Graduation Cap Map Pin Map Search Phone Pills Podcast

ACO Report

MUSC Health Alliance

ACO Name & Location
MUSC Health Alliance, LLC
96 Jonathan Lucas Street
Suite 601-J, CSB MSC 617
Charleston, South Carolina 29425

ACO Primary Contact
David S. Louder, M.D., MBA, FAAP
843-876-2811
louder@musc.edu

Organizational Information

ACO Participants

ACO Participant in Joint Venture (Y or N)

University Medical Associates

N

Carolina Family Care Inc

N

Medical University Hospital Authority

N

MUSC Health Partners

N

 

 ACO Governing Body 

Last Name

First Name

Title/Position

Voting Power

Membership Type

TIN Legal Business Name/DBA

Battle

James

Board Member

1

ACO Participant Representative

Medical University Hospital Authority

Cawley

Patrick

Chair

1

ACO Participant Representative

University Medical Associates

Fisher

Janie

Board Member

1

Medicare Beneficiary Representative

N/A

Lemon

James

Board Member

1

ACO Participant Representative

Medical University Hospital Authority

Louder

David

Executive Director/Medical Director

0

ACO Participant Representative

University Medical Associates

Ramsey

Gina

Treasurer

1

ACO Participant Representative

University Medical Associates

Steyer

Terry

Board Member

1

ACO Participant Representative

University Medical Associates

Thomas

Charles

Board Member

1

ACO Participant Representative

Medical University Hospital Authority

Zwerner

Peter

Vice-Chair/Secretary

1

ACO Participant Representative

University Medical Associates

Key ACO Clinical & Administrative Leadership

  • David Louder - ACO Executive
  • David Louder - Medical Director
  • Julie Acker - Compliance Officer
  • Danielle Scheurer - Quality Assurance/Improvement Officer

Associated Committees & Committee Leadership

  • Clinical Transformation and Quality - David Louder, M.D. & Danielle Scheurer, M.D., Co-Chairs
  • Finance and Contracting - Gina Ramsey  & Karyn Rae, Co-Chairs
  • Affilaitions and Compliance - Matt Severance & Julie Acker, Co-Chairs
  • IT and Analytics - Matt Turner & Patterson Burch, Co-Chairs

Types of ACO Participants or Combinations of Participants That Formed the ACO

  • ACO professionals in a group practice arrangement
  • Networks of individual practices of ACO professionals
  • Hospital employing ACO professionals

Shared Savings & Losses 

Amount of Shared Savings/Losses

  • N/A

Shared Savings Distribution

  • N/A

Quality Performance Results

 2016 Quality Performance Results:

ACO#

Measure Name

Rate

ACO Mean

ACO-1

CAHPS: Getting Timely Care, Appointments, and Information

N/A

80.51

ACO-2

CAHPS: How Well Your Providers Communicate

N/A

93.01

ACO-3

CAHPS: Patients' Rating of Provider

N/A

92.25

ACO-4

CAHPS: Access to Specialists

N/A

83.49

ACO-5

CAHPS: Health Promotion and Education

N/A

60.32

ACO-6

CAHPS: Shared Decision Making

N/A

75.40

ACO-7

CAHPS: Health Status/Functional Status

N/A

72.30

ACO-34

CAHPS: Stewardship of Patient Resources

N/A

26.97

ACO-8

Risk-Standardized, All Condition Readmission

N/A

14.70

ACO-35

Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)

N/A

18.17

ACO-36

All-Cause Unplanned Admissions for Patients with Diabetes

N/A

53.20

ACO-37

All-Cause Unplanned Admissions for Patients with Heart Failure

N/A

75.23

ACO-38

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

N/A

59.81

ACO-9

Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)

N/A

9.27

ACO-10

Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8)

N/A

14.53

ACO-11

Percent of PCPs who Successfully Meet Meaningful Use Requirements

N/A

82.72

ACO-39

Documentation of Current Medications in the Medical Record

N/A

87.54

ACO-13

Falls: Screening for Future Fall Risk

N/A

64.04

ACO-14

Preventive Care and Screening: Influenza Immunization

N/A

68.32

ACO-15

Pneumonia Vaccination Status for Older Adults

N/A

69.21

ACO-16

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up

N/A

74.45

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

N/A

90.98

ACO-18

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

N/A

53.63

ACO-19

Colorectal Cancer Screening

N/A

61.52

ACO-20

Breast Cancer Screening

N/A

67.61

ACO-21

Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented

N/A

76.79

ACO-42

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

N/A

77.72

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control

N/A

18.24

ACO-41

Diabetes: Eye Exam

N/A

44.94

ACO-28

Hypertension (HTN): Controlling High Blood Pressure

N/A

70.69

ACO-30

Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic

N/A

85.05

ACO-31

Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

N/A

88.67

ACO-33

Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<>

N/A

79.67

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.   

Payment Rule Waivers

  • Our ACO does use the SNF 3-Day Rule Waiver, effective January 1, 2018.